ANEBULO PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
ANEBULO PHARMACEUTICALS, INC. (ANEB) had Shares Outstanding (Cover Page) of 40.78 million shares as of 2026-02-06, per its 10-Q filed 2026-02-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-02-12
- 2026-02-06: Entity Common Stock, Shares Outstanding 40.78M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 41.08M shares.
- 2025-09-25: Entity Common Stock, Shares Outstanding 41.08M shares.
- 2025-05-08: Entity Common Stock, Shares Outstanding 41.08M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-02-06 | 40.78M shares 10-Q · filed 2026-02-12 |
| 2025-11-07 | 41.08M shares 10-Q · filed 2025-11-13 |
| 2025-09-25 | 41.08M shares 10-K · filed 2025-09-29 |
| 2025-05-08 | 41.08M shares 10-Q · filed 2025-05-13 |
| 2025-02-06 | 41.08M shares 10-Q · filed 2025-02-14 |
| 2024-11-06 | 25.93M shares 10-Q · filed 2024-11-13 |
| 2024-09-20 | 25.93M shares 10-K · filed 2024-09-25 |
| 2024-05-06 | 25.93M shares 10-Q · filed 2024-05-15 |
| 2024-02-06 | 25.93M shares 10-Q · filed 2024-02-13 |
| 2023-11-06 | 25.63M shares 10-Q · filed 2023-11-14 |
| 2023-09-14 | 25.63M shares 10-K · filed 2023-09-22 |
| 2023-05-09 | 25.63M shares 10-Q · filed 2023-05-11 |
| 2023-02-08 | 25.63M shares 10-Q · filed 2023-02-10 |
| 2022-11-07 | 25.63M shares 10-Q · filed 2022-11-10 |
| 2022-09-01 | 23.37M shares 10-K · filed 2022-09-09 |
| 2022-05-10 | 23.34M shares 10-Q · filed 2022-05-11 |
| 2022-02-11 | 23.34M shares 10-Q · filed 2022-02-11 |
| 2021-11-12 | 23.34M shares 10-Q · filed 2021-11-12 |
| 2021-09-15 | 23.34M shares 10-K · filed 2021-09-22 |
| 2021-06-16 | 23.34M shares 10-Q · filed 2021-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |